NYSE - Delayed Quote USD
Quest Diagnostics Incorporated (DGX)
175.87
+2.30
+(1.33%)
At close: April 24 at 4:00:02 PM EDT
175.80
-0.07
(-0.04%)
After hours: April 24 at 7:10:51 PM EDT
Insider Purchases Last 6 Months
| Shares | Transactions | |
|---|---|---|
| Purchases | 663,407 | 45 |
| Sales | 352,041 | 23 |
| Net Shares Purchased (Sold) | 311,366 | 68 |
| Total Insider Shares Held | 454.72k | -- |
| % Net Shares Purchased (Sold) | 217.60% | -- |
Net Institutional Purchases Prior Quarter to Latest Quarter
| Shares | |
|---|---|
| Net Shares Purchased (Sold) | -- |
| % Change in Institutional Shares Held | -- |
Insider Transactions Reported - Last Two Years
| Insider | Transaction | Type | Value | Date |
|---|---|---|---|---|
| KUPPUSAMY KARTHIK Officer | Sale at price 170.00 per share. | Direct | 434,350 | Apr 2, 2025 |
| DAVIS JAMES E Chief Executive Officer | Sale at price 167.86 - 169.63 per share. | Direct | 6,602,074 | Apr 2, 2025 |
| PREVOZNIK MICHAEL E General Counsel | Sale at price 170.00 per share. | Direct | 789,310 | Mar 17, 2025 |
| DOHERTY CATHERINE T Officer | Sale at price 174.13 per share. | Direct | 935,078 | Mar 5, 2025 |
| PREVOZNIK MICHAEL E General Counsel | Sale at price 175.79 per share. | Direct | 104,068 | Mar 4, 2025 |
| DOHERTY CATHERINE T Officer | Sale at price 175.79 per share. | Direct | 125,866 | Mar 4, 2025 |
| PREVOZNIK MICHAEL E General Counsel | Stock Award(Grant) at price 173.74 per share. | Direct | 1,485,303 | Mar 4, 2025 |
| DOHERTY CATHERINE T Officer | Stock Award(Grant) at price 173.74 per share. | Direct | 1,803,421 | Mar 4, 2025 |
| PLEWMAN PATRICK Officer | Stock Award(Grant) at price 173.74 per share. | Direct | 985,801 | Mar 4, 2025 |
| SAMAD SAMER ABDUL Chief Financial Officer | Stock Award(Grant) at price 173.74 per share. | Direct | 2,412,206 | Mar 4, 2025 |
| DEPPE MICHAEL J Officer | Stock Award(Grant) at price 173.74 per share. | Direct | 297,269 | Mar 4, 2025 |
| KUPPUSAMY KARTHIK Officer | Stock Award(Grant) at price 173.74 per share. | Direct | 770,363 | Mar 4, 2025 |
| DELANEY MARK E Officer | Stock Award(Grant) at price 173.74 per share. | Direct | 923,776 | Mar 4, 2025 |
| DAVIS J E CAUSEY Chief Executive Officer | Stock Award(Grant) at price 173.74 per share. | Direct | 10,757,460 | Mar 4, 2025 |
| DAVIS JAMES E Chief Executive Officer | Stock Award(Grant) at price 173.74 per share. | Direct | 10,757,460 | Mar 4, 2025 |
| PREVOZNIK MICHAEL E General Counsel | Sale at price 172.61 per share. | Direct | 91,138 | Feb 27, 2025 |
| DOHERTY CATHERINE T Officer | Sale at price 172.61 per share. | Direct | 142,231 | Feb 27, 2025 |
| PREVOZNIK MICHAEL E General Counsel | Sale at price 170.99 per share. | Direct | 103,278 | Feb 20, 2025 |
| DOHERTY CATHERINE T Officer | Sale at price 169.71 - 170.99 per share. | Direct | 244,515 | Feb 20, 2025 |
| PLEWMAN PATRICK Officer | Sale at price 169.71 per share. | Direct | 54,307 | Feb 19, 2025 |
| PREVOZNIK MICHAEL E General Counsel | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Feb 12, 2025 |
| DOHERTY CATHERINE T Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Feb 12, 2025 |
| PLEWMAN PATRICK Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Feb 12, 2025 |
| SAMAD SAMER ABDUL Chief Financial Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Feb 12, 2025 |
| DEPPE MICHAEL J Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Feb 12, 2025 |
| KUPPUSAMY KARTHIK Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Feb 12, 2025 |
| DELANEY MARK E Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Feb 12, 2025 |
| DAVIS J E CAUSEY Chief Executive Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Feb 12, 2025 |
| DAVIS JAMES E Chief Executive Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Feb 12, 2025 |
| GREGG VICKY B Director | Sale at price 164.57 per share. | Direct | 205,710 | Feb 5, 2025 |
| DELANEY MARK E Officer | Sale at price 164.30 per share. | Direct | 66,214 | Feb 5, 2025 |
| PLEWMAN PATRICK Officer | Purchase at price 158.04 per share. | Direct | 9,008 | Jan 29, 2025 |
| GREGG VICKY B Director | Purchase at price 158.04 per share. | Direct | 11,379 | Jan 29, 2025 |
| SAMAD SAMER ABDUL Chief Financial Officer | Purchase at price 158.04 per share. | Direct | 5,531 | Jan 29, 2025 |
| KUPPUSAMY KARTHIK Officer | Purchase at price 158.03 per share. | Direct | 1,896 | Jan 29, 2025 |
| DELANEY MARK E Officer | Purchase at price 158.02 per share. | Direct | 632 | Jan 29, 2025 |
| PREVOZNIK MICHAEL E General Counsel | Sale at price 162.26 - 163.15 per share. | Direct | 5,731,302 | Nov 29, 2024 |
| PREVOZNIK MICHAEL E General Counsel | Conversion of Exercise of derivative security at price 86.63 per share. | Direct | 3,044,698 | Nov 29, 2024 |
| DOHERTY CATHERINE T Officer | Sale at price 162.14 - 163.13 per share. | Direct | 5,395,484 | Nov 27, 2024 |
| DOHERTY CATHERINE T Officer | Conversion of Exercise of derivative security at price 103.57 per share. | Direct | 3,428,478 | Nov 27, 2024 |
| DEPPE MICHAEL J Officer | Sale at price 152.70 - 154.74 per share. | Direct | 2,889,123 | Nov 6, 2024 |
| DEPPE MICHAEL J Officer | Conversion of Exercise of derivative security at price 66.51 - 71.17 per share. | Direct | 1,287,634 | Nov 6, 2024 |
| KUPPUSAMY KARTHIK Officer | Sale at price 156.92 per share. | Direct | 278,525 | Oct 28, 2024 |
| PLEWMAN PATRICK Officer | Purchase at price 149.37 per share. | Direct | 8,962 | Oct 21, 2024 |
| GREGG VICKY B Director | Purchase at price 149.37 per share. | Direct | 11,352 | Oct 21, 2024 |
| SAMAD SAMER ABDUL Chief Financial Officer | Purchase at price 149.37 per share. | Direct | 5,527 | Oct 21, 2024 |
| KUPPUSAMY KARTHIK Officer | Purchase at price 149.37 per share. | Direct | 3,137 | Oct 21, 2024 |
| DELANEY MARK E Officer | Purchase at price 149.39 per share. | Direct | 598 | Oct 21, 2024 |
| PREVOZNIK MICHAEL E General Counsel | Sale at price 154.97 per share. | Direct | 5,044,516 | Aug 29, 2024 |
| PREVOZNIK MICHAEL E General Counsel | Conversion of Exercise of derivative security at price 95.80 per share. | Direct | 3,118,223 | Aug 29, 2024 |
Related Tickers
LH Labcorp Holdings Inc.
228.58
+1.98%
DHR Danaher Corporation
196.50
+0.10%
MEDP Medpace Holdings, Inc.
302.88
+4.25%
TMO Thermo Fisher Scientific Inc.
426.66
-1.15%
MTD Mettler-Toledo International Inc.
1,075.00
+2.75%
GH Guardant Health, Inc.
47.41
+3.88%
WAT Waters Corporation
340.70
+1.74%
NTRA Natera, Inc.
154.48
+3.98%
IDXX IDEXX Laboratories, Inc.
440.98
+3.36%
WGS GeneDx Holdings Corp.
109.39
+3.50%